Skip to content

Medical emergency? What to do

Lawmakers spar over Medicare drug coverage

3-RXPublished September 22, 20053 min read

Key points

  • Just days before Medicare officials in Washington unveil the private prescription drug plans that will be available to the program's 43 million elderly and disabled beneficiaries starting next January, both liberals and conservatives in Congress are calling for a delay in the controversial program.
  • "Many of us thought even before Katrina we couldn't afford this benefit," said Rep.
  • Of particular concern, say advocates for the poor, are the Medicare beneficiaries whose drug costs are currently covered by the Medicaid health program.
  • The Bush administration and Republican leaders in Congress -- who consider the drug benefit their signature legislative achievement of the past four years -- are struggling to keep the program on track.

Just days before Medicare officials in Washington unveil the private prescription drug plans that will be available to the program's 43 million elderly and disabled beneficiaries starting next January, both liberals and conservatives in Congress are calling for a delay in the controversial program.

Conservatives in the U.S. House Wednesday unveiled "Operation Offset," an effort to find budget cuts to help pay for relief needed to rebuild the states and cities decimated by Hurricane Katrina three weeks ago. Delaying the new Medicare benefit by a year is at the top of the list, primarily because it would save an estimated $30 billion over the next decade.

"Many of us thought even before Katrina we couldn't afford this benefit," said Rep. Jeff Flake, Republican from Arizona. "We certainly today have to think we should put this benefit off."

Meanwhile, Democrats in the House and Senate have proposed to delay the benefit's rollout, at least in the states directly hit by the hurricane and the surrounding states that are temporarily hosting most of the evacuees.

Of particular concern, say advocates for the poor, are the Medicare beneficiaries whose drug costs are currently covered by the Medicaid health program. Those patients -- many of them very old or institutionalized, will be automatically assigned to a drug plan this fall.

But Ruth Kennedy, deputy Medicaid director in Louisiana, says she's not sure all of her state's 100,000 "dual eligibles" can even be located at this point. As a result, many might not know how to obtain drugs when their Medicaid drug coverage ends Dec. 31.

The Bush administration and Republican leaders in Congress -- who consider the drug benefit their signature legislative achievement of the past four years -- are struggling to keep the program on track. House Majority Leader Tom DeLay, Republican from Texas, who encouraged the conservative group to develop ways to pay for hurricane relief, nevertheless called the proposal for delay "a nonstarter."

And Medicare and Medicaid Director Mark McClellan has been adamant that the program will proceed as scheduled, with notices going out early next month, and enrollment in plans beginning November 15. "There will be no delay in the drug benefit -- I don't know how many times I can say it," McClellan told reporters Tuesday following a speech to a Medicaid reform conference.

During his speech, to a conference sponsored by the Center for Health Care Transformation, McClellan said the drug benefit is even more important in the wake of the storm, because it will provide so much help to so many low-income Medicare beneficiaries. "One in three Medicare beneficiaries will have access to coverage that will pay on average 95 percent of their drug costs," he said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.